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Background: Female immigration in Catalonia, Spain, increased dramatically in the last
10 years. The Public Health system in the Region, provides a free of charge opportunistic
cervical cancer screening.
Aim:This study examines cervical cancer screening coverage and prevalence of cytology
abnormalities in Catalonia by immigration status.
Methods: The study analyzes the cytologies registered among women aged 25–65 that
have been attended at the Primary Health Centers (PHC) for any reason (n=1,242,230) dur-
ing 2008–2011. Coverage was estimated from Governmental data base Information System
Primary Care (SISAP) that includes 77% of PHC.The database is anonymous, and includes
information on age, country of birth, diagnostic center, and cytology results.
Results: During the period 2008–2011, 642,643 smears were performed in a total of
506,189 women over 14 years, of whom 18.3% were immigrants. Cytology coverage was
higher among immigrant women compared to Spanish born (51.2 and 39% respectively).
Immigrant women also had a higher prevalence of abnormal Paps compared to the Spanish
population, 4.5 and 2.9% respectively (p<0.001).
Conclusion: Immigrant women in Catalonia had a high access to the Public Health Services
and to cervical cancer screening facilities.The higher prevalence of abnormal cytologies in
immigrant women compared to native women indicates the relevance to prioritize cervical
cancer screening activities on a regular base in new comers.
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INTRODUCTION
In 2011 in Catalonia, a region in the North-East part of Spain,
15.7% of the population had been born outside Spain (1). The
migration growth had been steady for the last 10 years at 1.2 per
1,000 inhabitants. Latin America and Northern-African countries
were the most common regions of migration origin (2).
Cervical cancer is the third most common cancer in women.
More than 85% of the global burden occurs in developing coun-
tries (3). Among all malignant tumors, cervical cancer is the one
which can be most effectively controlled by screening (4). In high-
income countries, the incidence is generally lower because of the
availability of cervical screening. Based on the country of origin
as a reflection of potential contrasting cultures with the reception
country, migrants may have particular characteristics that pose
them to a differential risk when compared to native population
in the destination country. While migrants may benefit of a bet-
ter access to qualified health attention they may also have higher
risk for certain diseases. Azerkan et al. (5) have been reporting
that migrant population in Sweden largely lowered their risk of
cervical cancer as compared to the country of origin but had a
lower coverage of cervical cancer screening coverage. However,
they identified an important variability in relation to the country
of origin (5).
In Catalonia in 2007, with an opportunistic screening, the
annual incidence rate of cervical cancer was 7 per 105 women and
the mortality rate was 1.2 per 105 women. The annual percentage
change of mortality during the period 1993–2007 was−4.0 (6, 7).
The aim of this study was to examine cervical cancer screening
coverage and prevalence of cytology abnormalities by immigra-
tion status among women attended within the Public Sector of
Catalonia during 2008–2011.
MATERIALS AND METHODS
The Catalan Health Care System is a public facility providing a
universal coverage guaranteed by the National Health Service (Cat-
Salut) integrating into a single network of public use all health and
social resources. The principle supplier of this system is the Catalan
Institute of Health (CIH) which provides services to about 75% of
the population. It is estimated that around 30% of the population
has double health insurance, public and private (8, 9).
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In Catalonia the cervical cancer screening is opportunistic. The
latest recommendations on screening protocols for cervical cancer
were introduced in 2006. Special emphasis was directed to increase
coverage among the under screened women above age 40 and to
reach a 3-year interval between cytologies for the target popu-
lation 25–65 years old (10). During the study period, foreigners
residing in Spain who were registered at the city council had the
same rights to health care as Spanish nationals, regardless of their
residence status (11, 12).
STUDY POPULATION
The study population consisted of all Spanish or immigrants
women living in Catalonia with a registered age of 25–65 years
old. Information on cytology(ies) performed at basic health areas
within the public health system were obtained for the study period
2008–2011. Data were extracted from the routine data base Sys-
tem of Primary Care (SISAP) which is used in 77% of the public
basic health areas (13). The available information consisted of
place and date of birth, collection of cytology and results, and the
health center identification. For this study immigrant population
was considered any person whose place of birth was registered as
being outside the Spanish territory.
Age was categorized in two groups: 25–39 and 40–65. Cytol-
ogy results were categorized following the Bethesda system (12).
The result of HSIL+ (including HSIL and suspected of can-
cer) was analyzed individually and by country of origin, using
the following 16 groups: Spanish-born (native women), Ocea-
nia, Caribbean, Central America, Eastern Asia, Eastern Europe,
North America, Northern Africa, Northern Europe, South Amer-
ica, South-Eastern Asia, South-Central Asia, Southern Europe
(without Spain), Sub-Saharan Africa, Western Asia, and Western
Europe (14).
Cytology results refer to Bethesda classification that classifies
as negative, atypical squamous cells of undetermined signifi-
cance (ASCUS), atypical glandular cells of undetermined sig-
nificance (AGUS), low grade intraepithelial lesions (LSIL), high
grade intraepithelial lesions (HSIL), and suspected carcinoma.
Whenever we refer to HSIL+ we include HSIL and suspicion of
cancer.
STATISTICAL ANALYSIS
The results for continuous variables are given as mean val-
ues and SD, and for categorical variables as percentages. We
used the chi-square test to compare proportion between groups
and Student’s t -test to compare continuous variables. To esti-
mate the coverage of cervical cancer screening, cytologies were
related to the eligible population to provide a sense of the
impact in the general population. Further, cytologies were also
related to women that had been attended in any of the pri-
mary health care center for any reason. To estimate the cov-
erage of cervical cancer screening, number of women with at
least one cytology in this period 2008–2011 was related to
either all eligible women or to those attended at the primary
health care facilities during the study period. Estimates are pro-
vided by geographical region of origin. Estimates are given as
percentage with 95% confidence intervals (CI). The interval
between two cytologies was estimated by selecting all women
that between January and December 2008 had a cytology with
a negative result and following them until December 2011 for
a second cytology within this period. A lineal regression model
between coverage and use of health services was constructed.
p-Values smaller than 0.05 were considered to be statistically
significant.
Data analyses were conducted using R (R Foundation for
Statistical Computing, Vienna, Austria; Version 2.14.0).
RESULTS
Figure 1 shows a flow chart that describes the inclusion of
participants in the study. Table 1 shows the characteristics
of the study population by immigration status for the period
2008–2011. A total of 642,643 cytologies were performed in
a total of 506,189 women 25–65 years old. Of them, 91,427
(18%) were immigrant. Women from Morocco, Ecuador, Bolivia,
Colombia, and Romania represented 51% of all immigrants
(data not shown). Spanish-born women were significantly older
than immigrants (mean age= 44.3 and 36.3 years respectively,
p-value< 0.001). The ratio of cytology per woman was sim-
ilar in the two groups and this was irrespective of cytology
results. However the ratio of cytology coverage among attended
FIGURE 1 | Flow chart describing the inclusion of participants in the
study.
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Table 1 | Characteristics of women aged 25–65 years old included in the evaluation of cervical cancer screening coverage in Catalonia during the
period 2008–2011 by immigration status.
Population 25–65 years old
Immigranta Spanish born p-Value* All populationb
(n=91,427) N (%) (n=414,752) N (%) (n=506,189) N (%)
No. of cytologies 115,488 527,143 642,643
No. of women with cytology 91,427 414,752 <0.001 506,189
Age, years (SD) 36.3 (8.2) 44.3 (11.0) <0.001 42.8 (11.0)
Ratio of cytology/women 1.26 1.27 1.27
Cytology coverage, % (CI 95%)
Eligible women in the target population
25–39 years old 38.6 (38.3–38.8) 30.9 (30.8–31.1) 32.8 (32.7–32.9)
40–65 years old 32.0 (31.7–32.3) 32.1 (32.0–32.2) 32.1 (32.0–32.2)
25–65 years old 36.4 (36.2–36.5) 31.6 (31.5–31.7) 32.4 (32.3–32.5)
Attended women in primary health care
25–39 years old 55.3 (55–55.6) 40.7 (40.5–40.8) 44.0 (43.8–44.1)
40–65 years old 43.6 (43.2–44) 38.0 (37.9–38.1) 38.5 (38.4–38.6)
25–65 years old 51.2 (51–51.5) 39.0 (38.9–39.1) 40.8 (40.7–40.8)
Cytology results <0.001
Number of women with positive cytology 4,072 (4.5) 12,190 (2.9) 16,262 (3.2)
Number of women with negative cytology 88,948 (97.3) 408,041 (98.4) 496,999 (98.2)
Compliance of second round of screening when the first cytology
was negative in 2008, %
43.1 50.7 50.2
No., number; SD, standard deviation; CI, confidence interval.
aRefers to those with place of birth was outside the Spanish territory. *p-Value was calculated using chi-square test to compare categorical variables and Student’s
t-test to compare continuous variables.
bInclude people without information of country of birth.
women by migration status and age strata showed that younger
immigrant women (<40) had higher coverage compared to their
elder women (>39) with a ratio of 1.26 while among Spanish
women the ratio was 1.07. Cytology coverage was statistically
higher among immigrants (51%) as compared to Spanish-born
women (39%). Similarly, immigrant women were more likely to
have an abnormal cytology compare to Spanish born (4.5 versus
2.9%, p-value< 0.001). Participation to second round screen-
ing among women with a normal cytology was lower among
immigrant women (43.1%) as compared to Spanish women
(50.7%).
Table 2 describes the immigrant population by region of ori-
gin and cytological coverage. The largest community of immi-
grants came from South America accounting for 51% of the
total immigrants. The largest contributing country was Ecuador
(13.5%). Cytology coverage was lower in South-Central Asia,
Western Europe, South-Eastern Asia, and North America, while it
was higher among women from Latin America and Sub-Saharan
Africa. Women from Northern and Sub-Saharan Africa and South-
Central Asia were more likely to use the Public Primary Health
Care Services compared to those from other regions. Oceania,
Eastern Asia, and North America were the groups with less use of
the health services.
Table 3 shows all cytological results by migration status per-
formed in women aged 25–65 years for the period 2008–2011.
Abnormal results were more common among immigrant women
as compared to Spanish born (4.5 versus 3%, p< 0.001) This was
explained by an increased in all categories. In particular the group
of HSIL and suspected cancer were twice as common as that
observed among Spanish women (p< 0.001). These differences
were observed among women within the age group 25–39 but not
among women above age 40 (Data not shown).
Figure 2 describes the distribution of abnormal diagnosis by
age group and by region of origin. Interestingly, women from
North America had highest percentage of abnormal cytologies
(6.9%), followed by women from Central America and Western
Europe (6.8 and 5.8%, respectively). In contrast, women from
Oceania and Northern Africa had the lowest percentages of abnor-
mal cytologies (0 and 2.6%, respectively). North American women
mainly contributed to abnormal cytologies in the age category of
25–39 years while Sub-Saharan African women were so in the age
group of 40–65 years.
Figure 3 shows the correlation between cytological coverage in
attended women and use of health services in Primary Care. We
found that South-Central and South-Eastern Asia were the regions
that presented less coverage in attended women but that used more
health services in Primary Care. In contrast, the region of Eastern
Asia showed to have cytology coverage close to the average one
but a lower use of health services. Despite of these differences we
did not find a statistically significant correlation between cytol-
ogy coverage and global use of primary health services within the
Public Sector.
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Table 2 | Region of origin of immigrant women from Catalonia by use of cervical cancer screening and primary health care services during the
period 2008–2011.
Region of origin Eligible
population
No. of women with at least
one cytology (%)
Attended
women
Cytology coverage in attended
women, % (CI 95%)
Use of primary health
care services
Europe 58,283 14,870 36,599 40.6 (40.1–41.1) 62.8
Southern Europe 8,516 2,285 5,313 43.0 (41.7–44.3) 62.4
Eastern Europe 38,507 10,084 24,554 41.1 (40.5–41.7) 63.8
Northern Europe 3,708 872 2,227 39.2 (37.1–41.2) 60.1
Western Europe 7,553 1,629 4,505 36.2 (34.8–37.6) 59.7
Africa 41,935 16,390 33,929 48.3 (47.8–48.8) 80.9
Sub-Saharan Africa 7,931 3,284 6,074 54.1 (52.8–55.3) 76.6
Northern Africa 34,004 13,106 27,855 47.1 (46.5–47.6) 81.9
Asia 20,907 5,247 12,756 41.1 (40.3–42.0) 61.0
Western Asia 2,623 741 1,623 45.7 (43.2–48.1) 61.9
Eastern Asia 11,292 2,712 5,967 45.4 (44.2–46.7) 52.8
South-Eastern Asia 1,665 428 1,102 38.8 (36.0–41.7) 66.2
South-Central Asia 5,327 1,366 4,064 33.6 (32.2–35.1) 76.3
America 130,200 54,890 95,102 57.7 (57.4–58.0) 73.0
South America 108,943 46,588 79,857 58.3 (58.0–58.7) 73.3
Central America 10,260 4,084 7,197 56.7 (55.6–57.9) 70.2
Caribbean 10,174 4,045 7,608 53.2 (52.0–54.3) 74.8
North America 823 173 440 39.3 (34.8–43.9) 53.5
Oceania 128 30 67 44.8 (32.9–56.7) 52.3
Women aged 25–65 years old.
Table 3 | Cytology results for women aged 25–65 years old that participated in cervical cancer screening in Catalonia during the period
2008–2011 by immigrant status.
Cytology results Immigrant N (%) Spanish born N (%) p-Value* All populationa N (%)
Negative cytology 108,940 (95.5) 506,567 (97) <0.001 615,519
Positive cytology 5,121 (4.5) 15,902 (3) 21,023
Results of cytology
ASCUS/AGUS 2,230 (1.9) 7,472 (1.4) <0.001 9,702 (1.5)
ASC-H 144 (0.1) 381 (0.07) <0.001 525 (0.08)
LSIL 2,056 (1.8) 6,390 (1.2) <0.001 8,446 (1.3)
HSIL 640 (0.6) 1,541 (0.3) <0.001 2,181 (0.4)
Suspected cancer 51 (0.04) 118 (0.02) <0.001 169 (0.03)
Without result of cytology 253 (0.2) 887 (0.2) 1,140 (0.2)
Not applicable 1,174 (1.2) 3,787 (0.7) 4,961 (1.0)
*p-Value was calculated using chi-square test to compare categorical variables.
aInclude people without information of country of birth.
DISCUSSION
Compared to the Spanish-born women, we identified that immi-
grant women had a higher coverage of cervical cytology within
the Public Health Sector. Among them, Latin American women
showed the highest coverage (51.2%). A higher proportion of
high grade intraepithelial lesions or more (HSIL+) was also
observed among immigrant women, particularly among women
from North and Central America.
We had previously estimated that cytology coverage in the
region over a 3 years period was around 40% for the overall popu-
lation irrespective of the place of birth (6). Immigrant women
had a slightly higher use of Public Health Care facilities and
also a higher cytological coverage than Spanish-born women.
As expected, women born in economically better-off economies
like Northern and Western Europe, and North America regis-
tered a lower coverage than the average. These differences could
more likely be attributed to a higher use of private Health Care
providers although cultural reasons cannot be dismissed. Con-
trary, idiomatic, cultural, and social factors are reasons more likely
to explained the lower coverage observed among women from
Southern Asian rather than a higher enrollment in the private
sector. This is consistent with a previous study exploring cancer
screening uptake in Spain were a lower use of breast and cervical
cancer screening activities were reported among women language
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FIGURE 2 | Prevalence of abnormal cytology in woman aged 25–65 years old by region of birth.
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FIGURE 3 | Correlation analysis between the use of health services and
the coverage of cytology by region of birth.
barriers like Asian countries in contrast with Latin American from
Central and South America countries (15). We suggest that the
language barrier could be a major limitation that explains why
Latin American women had higher access to the services. This
contrast with our estimates that general use of primary health ser-
vices for any medical reason was higher among women born in
Northern-African countries with French or Arab as main com-
munication language. Religion and health perception may play
also an important role in the decision of searching for gynecolog-
ical exams among asymptomatic women within universal health
coverage facilities.
An interesting fact is that Azerkan et al. (5) showed that immi-
grants in Sweden from North-America, Denmark, or Norway had
lower participation in screening programs, as compared to immi-
grants from Africa or Latin American countries. These differences
are indicative, along with our results, that determinants of cervical
cancer screening attendance are complex. Azerkan et al. further
explored the reasons why other Scandinavian countries’ women
immigrating to Sweden were not participating so regularly to the
screening activities as Swedish women did (5). A qualitative study
identified that absence of screening was not directly related to
avoidance but to work and life overload in women within the
reproductive ages. These observations are also consistent with
other studies (16).
On the other hand, age may be an important determinant of
cytology uptake among women irrespective of the country of birth
(17, 18). Overall immigrant population were younger and within
the reproductive age period than Spanish born, thus age stratified
analysis may better to reflect any difference in health care access.
Consistently we found that women irrespective of the country of
origin between 40 and 65 years old had a lower participation rate
than younger women. Unfortunately we could not verify whether
this observation was related to the residence period, education, or
socio-economic level as observed in other studies (5, 15, 18–20).
A low percentage of immigrant women returned after the
3 years period as recommended by the screening protocol (10).
Around 57% of immigrant women with a negative cytology did
not return for the next screening round versus the also low, 50%,
attendance observed in the Spanish-born population. We believe
that this low attendance for the next screening round of both pop-
ulation groups is likely due to the changes in the recommendations
by which women have gone from 1-year screen interval to 3-year
interval. It may be easier for the women to forget about the need
of a cytology unless there is a system for recall. We have observed,
in a pilot study, that individual call-recall increased substantially
the participation (17).
Immigrant women had a higher proportion of abnormal
cytologies versus Spanish women. Over the approximately 600,000
cytologies registered during the 2008–2011 period, an 18% cor-
responded to immigrant women from which HSIL+ diagnosis
were twice as high as that detected in Spanish-born women. These
lesions were mainly detected in women 25–39 years old. On the
contrary, immigrant women within the age range of 40–65 years
had lower percentage of HSIL+ than native women. Women from
North America had the highest prevalence of HSIL+ in all range of
ages. Although based in low numbers it was surprising to observe
a low cytological coverage and a high HSIL+. Both aspects could
be speculated to be related to differential referral patterns. Women
born in North America may have a higher socio-economic status
and use more the private gynecological services. When an abnor-
mal result is diagnosed the women may opt to attend a free of
charge services.
On the other hand, women from North of Africa had a
lower percentage of HSIL+ compared to Spanish-born women.
These results confirm the consistently low incidence rates of
cervical cancer observed in populations with Islam as reli-
gion (14).
The main strength of this study is the analysis of immigrant
population evaluating the medical records of the public health
system in the opportunistic screening of cervical cancer in Cat-
alonia. Until now, most studies had used national health surveys
or questionnaires for analysis of cervical cytology coverage and
its determinants (8, 21). However, the use of electronic medical
records eliminates the bias that exists in these types of studies. The
inclusion of a large proportion of women living in Catalonia is
also strength of this study.
We would have liked to evaluate our data using information
on educational level, socio-economic factors, or years since immi-
gration. These are important variables related to the participation
in cervical cancer screening (5, 22). Efforts to further investigate
these factors are on-going for future analyses. The available infor-
mation was restricted to the one registered within the public health
care system. This may underestimate the real coverage if women
use both private and public systems selectively for certain special-
ties like gynecology. However our results on the overall cytological
coverage, are aligned with those reported by personal interviews
in surveys (21, 23).
Some studies have shown that immigrant population has a high
mobility affecting the stability of health statistics (5). We have
observed that about 5% of the immigrant population tends to
change area of residence or quit the health system. We believe that
this proportion is unlikely to greatly affect our results.
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In summary, immigrant women in Catalonia participating in
cervical cancer screening had a greater coverage and higher preva-
lence of cytological abnormalities, but lower participation in a
second screening round versus native women. Immigrant women
should be strongly recommended to participate in the screening
activities on a regular base.
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